Checkpoint Therapeutics Announces Formation of Scientific Advisory Board
Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights